Abiopharma

Volition Continues to Extend Access to Nu.Q® Vet Cancer Test

Dermata Receives Notice of Grant of Patent for Next-Generation Acne Treatment by Australian Patent Office

New Expert Consensus Published in The Laryngoscope Recommends PAPZIMEOS (zopapogene imadenovec) as the New Standard of Care First-Line Treatment for Adults with Recurrent Respiratory Papillomatosis

CoyaTherapeutics - Coya Therapeutics CEO Dr. Arun Swaminathan Issues Letter to Stockholders

LIXTE Biotechnology Attending the DealFlow Discovery Conference, January 28-29

Avanos Medical and Siemens Healthineers Collaborate to Advance Integrated Solutions for Outpatient and Interventional Pain Management

Lipocine Announces Completion of Enrollment and Dosing in Phase 3 Trial of LPCN 1154 in Postpartum Depression (PPD)

Lillys sofetabart mipitecan receives U.S. FDAs Breakthrough Therapy designation for the treatment of certain patients with platinum-resistant ovarian cancer

Novavax Announces Entering into a License Agreement with Pfizer

NervGen Pharma to Ring the Nasdaq Closing Bell on January 22, 2026, Celebrating Its Recent Nasdaq Listing